Animal Model of Severe Fever With Thrombocytopenia Syndrome Virus Infection
暂无分享,去创建一个
Xiulian Sun | Huálín Wáng | Yuan-Qin Min | Y. Ning | Fei Deng | Jiawen Sun | Yunjie Li | Jiawen Sun
[1] L. Bao,et al. The Ablation of Envelope Protein Glycosylation Enhances the Neurovirulence of ZIKV and Cell Apoptosis in Newborn Mice , 2021, Journal of immunology research.
[2] T. Nabeshima,et al. Severe Fever with Thrombocytopenia Syndrome in Cats and Its Prevalence among Veterinarian Staff Members in Nagasaki, Japan , 2021, Viruses.
[3] Zhiwei Wu,et al. Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome , 2021, PLoS pathogens.
[4] XianWei Wang,et al. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice. , 2021, Veterinary microbiology.
[5] Jian-wei Liu,et al. SFTSV Infection Induced Interleukin-1β Secretion Through NLRP3 Inflammasome Activation , 2021, Frontiers in Immunology.
[6] M. Shimojima,et al. Pathological Characteristics of a Patient with Severe Fever with Thrombocytopenia Syndrome (SFTS) Infected with SFTS Virus through a Sick Cat’s Bite , 2021, Viruses.
[7] Y. Kirino,et al. Direct Transmission of Severe Fever with Thrombocytopenia Syndrome Virus from Domestic Cat to Veterinary Personnel , 2020, Emerging infectious diseases.
[8] F. Dèng,et al. Host restriction of emerging high-pathogenic bunyaviruses via MOV10 by targeting viral nucleoprotein and blocking ribonucleoprotein assembly , 2020, PLoS pathogens.
[9] Tadaki Suzuki,et al. Virus-infected peripheral blood plasmablasts in a patient with severe fever with thrombocytopenia syndrome , 2020, International Journal of Hematology.
[10] H. Feldmann,et al. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus , 2020, bioRxiv.
[11] S. Eo,et al. Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling , 2020, Laboratory animal research.
[12] Steven B. Bradfute,et al. 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. , 2020, Archives of virology.
[13] J. Kuhn,et al. A Model for the Production of Regulatory Grade Viral Hemorrhagic Fever Exposure Stocks: From Field Surveillance to Advanced Characterization of SFTSV , 2020, Viruses.
[14] M. Shimojima,et al. A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome , 2020, bioRxiv.
[15] Bian-Li Xu,et al. Severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis of epidemiology, clinical signs, routine laboratory diagnosis, risk factors, and outcomes , 2020, BMC Infectious Diseases.
[16] Nam-Hyuk Cho,et al. Genotypic Heterogeneity of Orientia tsutsugamushi in Scrub Typhus Patients and Thrombocytopenia Syndrome Co-infection, Myanmar , 2020, Emerging infectious diseases.
[17] Yan Li,et al. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy , 2020, Science.
[18] Zhiwei Wu,et al. A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo. , 2020, JCI insight.
[19] H. Wen,et al. Severe fever with thrombocytopenia syndrome virus infection during pregnancy in C57/BL6 mice causes fetal damage , 2020, PLoS neglected tropical diseases.
[20] Hongbin He,et al. Recombinant Human Adenovirus Type 5 Co-expressing RABV G and SFTSV Gn Induces Protective Immunity Against Rabies Virus and Severe Fever With Thrombocytopenia Syndrome Virus in Mice , 2020, Frontiers in Microbiology.
[21] F. Dèng,et al. A RIG-I–like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination , 2020, The Journal of Biological Chemistry.
[22] M. Hu,et al. Structure of severe fever with thrombocytopenia syndrome virus L protein elucidates the mechanisms of viral transcription initiation , 2020, Nature Microbiology.
[23] Eun-Ha Kim,et al. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets , 2020, Cell Host & Microbe.
[24] F. Dèng,et al. Guertu virus NSs protein disrupts host defense by blocking antiviral interferon induction and action. , 2020, ACS infectious diseases.
[25] S. Günther,et al. Structural and functional characterization of the severe fever with thrombocytopenia syndrome virus L protein , 2020, bioRxiv.
[26] M. Saijo,et al. Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection , 2020, Frontiers in Microbiology.
[27] M. Shimojima,et al. Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections. , 2020, The Journal of clinical investigation.
[28] H. Shimoda,et al. The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan , 2020, Emerging microbes & infections.
[29] Jungsang Ryou,et al. Genetic and Pathogenic-Diversity of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) in South Korea. , 2019, JCI insight.
[30] Jae U. Jung,et al. Cross-genotype protection of live-attenuated vaccine candidate for severe fever with thrombocytopenia syndrome virus in a ferret model , 2019, Proceedings of the National Academy of Sciences.
[31] Y. Jeon,et al. Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice , 2019, bioRxiv.
[32] T. Steiner,et al. Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice , 2019, Pathogens.
[33] H. Ebihara,et al. Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses , 2019, Vaccines.
[34] Geng-fu Xiao,et al. Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality , 2019, Cell Research.
[35] Jae U. Jung,et al. Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets , 2019, Nature Communications.
[36] M. Shimojima,et al. Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats , 2019, Scientific Reports.
[37] Su-Jin Park,et al. Shedding and Transmission Modes of Severe Fever With Thrombocytopenia Syndrome Phlebovirus in a Ferret Model , 2019, Open forum infectious diseases.
[38] Zheng Xing,et al. Susceptibility of spotted doves (Streptopelia chinensis) to experimental infection with the severe fever with thrombocytopenia syndrome phlebovirus , 2019, PLoS neglected tropical diseases.
[39] Todd M. Allen,et al. Humanized immune system mouse models: progress, challenges and opportunities , 2019, Nature Immunology.
[40] Zhìhóng Hú,et al. Interferon-γ-Directed Inhibition of a Novel High-Pathogenic Phlebovirus and Viral Antagonism of the Antiviral Signaling by Targeting STAT1 , 2019, Front. Immunol..
[41] W. Choi,et al. Nosocomial person-to-person transmission of severe fever with thrombocytopenia syndrome. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[42] Xuan Chuong Tran,et al. Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam , 2019, Emerging infectious diseases.
[43] Zhìhóng Hú,et al. Heartland virus antagonizes type I and III interferon antiviral signaling by inhibiting phosphorylation and nuclear translocation of STAT2 and STAT1 , 2019, The Journal of Biological Chemistry.
[44] Saori Sakabe,et al. Species-Specific Pathogenicity of Severe Fever with Thrombocytopenia Syndrome Virus Is Determined by Anti-STAT2 Activity of NSs , 2019, Journal of Virology.
[45] J. Chae,et al. Severe Fever with Thrombocytopenia Syndrome Virus in Dogs, South Korea , 2019, Emerging infectious diseases.
[46] K. Chandran,et al. Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus , 2019, npj Vaccines.
[47] P. Tsichlis,et al. Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis , 2019, Nature Microbiology.
[48] Su-Jin Park,et al. Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis , 2018, Nature Microbiology.
[49] D. Smee,et al. 2′‐Fluoro‐2′‐deoxycytidine is a broad‐spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models , 2018, Antiviral research.
[50] Jinhe Kim,et al. An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus , 2018, bioRxiv.
[51] W. Cao,et al. Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study. , 2018, The Lancet. Infectious diseases.
[52] M. Saijo. Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[53] M. Shimojima,et al. Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration , 2018, bioRxiv.
[54] P. Thomas,et al. Moving Forward: Recent Developments for the Ferret Biomedical Research Model , 2018, mBio.
[55] Shibo Li,et al. Multiple organ involvement in severe fever with thrombocytopenia syndrome: an immunohistochemical finding in a fatal case , 2018, Virology Journal.
[56] G. Gao,et al. Bunyavirales ribonucleoproteins: the viral replication and transcription machinery , 2018, Critical reviews in microbiology.
[57] M. Shimojima,et al. A patient with severe fever with thrombocytopenia syndrome and hemophagocytic lymphohistiocytosis-associated involvement of the central nervous system. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[58] Yeu‐Chun Kim,et al. Nano-patterning of a stainless steel microneedle surface to improve the dip-coating efficiency of a DNA vaccine and its immune response. , 2017, Colloids and surfaces. B, Biointerfaces.
[59] Zhìhóng Hú,et al. Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase–IRF3 transcription factor interaction and signaling required for interferon induction , 2017, The Journal of Biological Chemistry.
[60] S. Ceman,et al. Mov10 suppresses retroelements and regulates neuronal development and function in the developing brain , 2017, BMC Biology.
[61] K. Shiogama,et al. Hemophagocytic Lymphohistiocytosis in a Fatal Case of Severe Fever with Thrombocytopenia Syndrome , 2017, Internal medicine.
[62] D. Greiner,et al. Humanized Mouse Models of Clinical Disease. , 2017, Annual review of pathology.
[63] H. Ebihara,et al. Animal Models of Emerging Tick-Borne Phleboviruses: Determining Target Cells in a Lethal Model of SFTSV Infection , 2017, Front. Microbiol..
[64] B. Gowen,et al. Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir , 2016, Journal of Virology.
[65] Laurence Zitvogel,et al. Mouse models in oncoimmunology , 2016, Nature Reviews Cancer.
[66] Haruo Watanabe,et al. Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus , 2016, mSphere.
[67] Zheng Xing,et al. Host Responses and Regulation by NFκB Signaling in the Liver and Liver Epithelial Cells Infected with A Novel Tick-borne Bunyavirus , 2015, Scientific Reports.
[68] De-xin Li,et al. [Infection of the Severe Fever with Thrombocytopenia Syndrome Virus in Balb/C Mice and Hamsters]. , 2015, Bing du xue bao = Chinese journal of virology.
[69] Guillermo Posadas-Herrera,et al. Therapeutic effect of post-exposure treatment with antiserum on severe fever with thrombocytopenia syndrome (SFTS) in a mouse model of SFTS virus infection , 2015, Virology.
[70] De-xin Li,et al. SFTS virus infection in nonhuman primates. , 2015, The Journal of infectious diseases.
[71] C. Rice,et al. Interferons and viruses: an evolutionary arms race of molecular interactions. , 2015, Trends in immunology.
[72] W. Cao,et al. Immunization with recombinant SFTSV/NSs protein does not promote virus clearance in SFTSV-infected C57BL/6J mice. , 2015, Viral immunology.
[73] Xue-Jie Yu,et al. Severe fever with thrombocytopenia syndrome and its pathogen SFTSV. , 2015, Microbes and infection.
[74] W. Cao,et al. Disruption of Type I Interferon Signaling by the Nonstructural Protein of Severe Fever with Thrombocytopenia Syndrome Virus via the Hijacking of STAT2 and STAT1 into Inclusion Bodies , 2015, Journal of Virology.
[75] A. Sher,et al. Type I interferons in infectious disease , 2015, Nature Reviews Immunology.
[76] M. Saijo,et al. Two autopsy cases of severe fever with thrombocytopenia syndrome (SFTS) in Japan: A pathognomonic histological feature and unique complication of SFTS , 2014, Pathology international.
[77] M. Pichichero,et al. Immune responses in neonates , 2014, Expert review of clinical immunology.
[78] B. He,et al. Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. , 2014, The Lancet. Infectious diseases.
[79] M. Han,et al. Severe Fever with Thrombocytopenia Syndrome Virus in Ticks Collected from Humans, South Korea, 2013 , 2014, Emerging infectious diseases.
[80] W. Liu,et al. Viral suppression of innate immunity via spatial isolation of TBK1/IKKε from mitochondrial antiviral platform , 2014, Journal of molecular cell biology.
[81] A. García-Sastre,et al. Hijacking of RIG-I Signaling Proteins into Virus-Induced Cytoplasmic Structures Correlates with the Inhibition of Type I Interferon Responses , 2014, Journal of Virology.
[82] Zheng Xing,et al. Evasion of Antiviral Immunity through Sequestering of TBK1/IKKε/IRF3 into Viral Inclusion Bodies , 2013, Journal of Virology.
[83] H. Lv,et al. Systematic review of severe fever with thrombocytopenia syndrome:virology, epidemiology, and clinical characteristics , 2013, Reviews in medical virology.
[84] R. Tesh,et al. The Pathogenesis of Severe Fever with Thrombocytopenia Syndrome Virus Infection in Alpha/Beta Interferon Knockout Mice: Insights into the Pathologic Mechanisms of a New Viral Hemorrhagic Fever , 2013, Journal of Virology.
[85] M. Shimojima,et al. The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan , 2013, The Journal of infectious diseases.
[86] Hao Yu,et al. An emerging hemorrhagic fever in China caused by a novel bunyavirus SFTSV , 2013, Science China Life Sciences.
[87] Z. Bi,et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. , 2012, The Journal of infectious diseases.
[88] A. MacNeil,et al. A new phlebovirus associated with severe febrile illness in Missouri. , 2012, The New England journal of medicine.
[89] Shiwen Wang,et al. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model , 2012, Proceedings of the National Academy of Sciences.
[90] Ming-hui Li,et al. Infection and pathogenesis of Huaiyangshan virus (a novel tick-borne bunyavirus) in laboratory rodents. , 2012, The Journal of general virology.
[91] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[92] Gabriele Neumann,et al. Experimental adaptation of an influenza H5 haemagglutinin (HA) confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets , 2012, Nature.
[93] J. Klena,et al. A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[94] Yuan Zhang,et al. Metagenomic Analysis of Fever, Thrombocytopenia and Leukopenia Syndrome (FTLS) in Henan Province, China: Discovery of a New Bunyavirus , 2011, PLoS pathogens.
[95] Weizhong Yang,et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. , 2011, The New England journal of medicine.
[96] Ming-hui Li,et al. Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China. , 2011, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[97] Ralph Baric,et al. A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice , 2007, PLoS pathogens.
[98] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[99] Osamu Takeuchi,et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.
[100] Z. Zhai,et al. VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .
[101] Zhijian J. Chen,et al. Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.
[102] C. Leclerc,et al. Neonatal adaptive immunity comes of age , 2004, Nature Reviews Immunology.
[103] Shizuo Akira,et al. TLR signaling pathways. , 2004, Seminars in immunology.
[104] S. Adunyah,et al. Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. , 1999, Biochemical and biophysical research communications.
[105] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[106] P. Heinrich,et al. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family , 1994, Molecular and cellular biology.
[107] M. Shimojima,et al. RLRs and TLRs Signaling Pathways Cause Aberrant Production of Inflammatory 1 Cytokines / Chemokines in an SFTSV Infection Mouse Model 2 3 , 2018 .
[108] Tadaki Suzuki,et al. Fatal Severe Fever with Thrombocytopenia Syndrome: An Autopsy Case Report. , 2016, Internal medicine.
[109] M. Han,et al. Severe Fever with Thrombocytopenia Syndrome Virus , 2014 .
[110] K. Bradford,et al. Development and Maturation , 2013 .
[111] D. Chaplin,et al. Development and maturation of secondary lymphoid tissues. , 1999, Annual review of immunology.
[112] M. Bray,et al. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. , 1998, The Journal of infectious diseases.
[113] A. Davies,et al. Immune Responses , 1971, Nature.
[114] George F. Dowdeswell,et al. On rabies , 1888, Proceedings of the Royal Society of London.